| COVID‐19 and liver disease—what we know on 1st May 2020 I Garrido, R Liberal, G Macedo Alimentary pharmacology & therapeutics 52 (2), 267-275, 2020 | 214 | 2020 |
| Autoimmune hepatitis after COVID-19 vaccine–more than a coincidence I Garrido, S Lopes, MS Simões, R Liberal, J Lopes, F Carneiro, G Macedo Journal of autoimmunity 125, 102741, 2021 | 88 | 2021 |
| Safety of COVID-19 vaccination in inflammatory bowel disease patients on biologic therapy I Garrido, S Lopes, G Macedo Journal of Crohn's and Colitis 16 (4), 687-688, 2022 | 15 | 2022 |
| Wilson disease in Northern Portugal: a long-term follow-up study I Garrido, M Marques, R Liberal, H Cardoso, S Lopes, G Macedo Orphanet Journal of Rare Diseases 17 (1), 82, 2022 | 10 | 2022 |
| Self-expandable metal stents in esophageal cancer before preoperative neoadjuvant therapy: efficacy, safety, and long-term outcomes E Rodrigues-Pinto, J Ferreira-Silva, B Sousa-Pinto, R Medas, I Garrido, ... Surgical Endoscopy 35, 5130-5139, 2021 | 7 | 2021 |
| Cirrhosis management in a major referral center during COVID-19 I Garrido, R Liberal, R Gaspar, G Macedo JHEP Reports 2 (5), 2020 | 7 | 2020 |
| Hit the road JAK! The role of new oral treatment in inflammatory bowel disease I Garrido, S Lopes, G Macedo Inflammatory Bowel Diseases 27 (12), 2010-2022, 2021 | 6 | 2021 |
| Duodenal-type follicular lymphoma: a silent tumor I Garrido, J Santos-Antunes, H Cardoso, G Macedo Rev Esp Enferm Dig 114 (8), 489-490, 2022 | 5 | 2022 |
| Hepatotoxicity in inflammatory bowel disease: mesalazine, the forgotten drug I Garrido, AL Santos, J Lopes, S Lopes, G Macedo European Journal of Gastroenterology & Hepatology 33 (1S), e1067-e1070, 2021 | 5 | 2021 |
| Trastuzumab emtansine-induced nodular regenerative hyperplasia: is dose reduction enough as a preventable measure? I Garrido, A Magalhães, J Lopes, G Macedo Digestive Diseases 40 (6), 787-792, 2022 | 4 | 2022 |
| Long-term follow-up and prognosis of celiac hepatitis I Garrido, R Liberal, A Peixoto, G Macedo European Journal of Gastroenterology & Hepatology 34 (12), 1255-1260, 2022 | 3 | 2022 |
| Kaposi’s sarcoma with atypical gastrointestinal involvement I Garrido, J Pacheco, R Coelho, G Macedo, G Isabel, P João, C Rosa Rev Esp Enferm Dig 114 (6), 350-1, 2022 | 3 | 2022 |
| Immune response induced by SARS-CoV-2 vaccines in patients with inflammatory bowel disease under biologic therapy I Garrido, S Lopes, P Andrade, AC Real, A Ramos, MJ Cardoso, ... Official journal of the American College of Gastroenterology| ACG 117 (3 …, 2022 | 3 | 2022 |
| Universal screening for hepatitis C—In for a penny, in for a pound I Garrido, G Macedo European Journal of Clinical Microbiology & Infectious Diseases 41 (3), 341-347, 2022 | 3 | 2022 |
| COVID-19 and celiac disease–concerns to be addressed I Garrido, A Peixoto, G Macedo European journal of gastroenterology & hepatology 33 (11), 1460-1461, 2021 | 3 | 2021 |
| universal screening for hepatitis C in pregnant women, children and adolescents. I Garrido, G Macedo Alimentary Pharmacology & Therapeutics 54 (7), 2021 | 3 | 2021 |
| Inflammatory bowel disease management in a major referral center during COVID-19 pandemic I Garrido, S Lopes, G Macedo Inflammatory bowel diseases 26 (10), e114-e115, 2020 | 3 | 2020 |
| liver disease and COVID‐19—not the perfect storm. Authors' reply” I Garrido, R Liberal, G Macedo Alimentary Pharmacology & Therapeutics 52 (3), 574, 2020 | 3 | 2020 |
| Importance of Extraintestinal Manifestations in Early Diagnosis of Gardner Syndrome B Besteiro, F Gomes, C Costa, R Portugal, I Garrido, J Almeida Case Reports in Gastrointestinal Medicine 2020 (1), 7394928, 2020 | 3 | 2020 |
| Longitudinal outcomes of obeticholic acid therapy in ursodiol‐nonresponsive primary biliary cholangitis: stratifying the impact of add‐on fibrates in real‐world practice E Gómez, JL Montero, E Molina, L Garcia‐Buey, M Casado, J Fuentes, ... Alimentary Pharmacology & Therapeutics, 2024 | 2 | 2024 |
